ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1475	National Cancer Institute	Html	en	Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult primary liver cancer.	HCC tumors 0.58507 Semin Liver Dis 0.618193 Hepatocellular carcinoma incidence 0.684284 PDQ cancer information 0.577886 American Cancer Society 0.586704 early hepatocellular carcinoma 0.666995 primary biliary cirrhosis 0.576504 chronic liver disease 0.578131 unresectable hepatocellular carcinoma 0.664574 blood flow 0.562662 hepatocellular carcinoma 0.977206 primary liver cancer 0.589429 Natural history 0.564684 cancer information summary 0.576375 risk factors 0.586296 normal liver parenchyma 0.570598 liver disease 0.607293 liver 0.658374 virus-related hepatocellular carcinoma 0.677568 western European patients 0.565566 patients 0.658086 HCC 0.686159 advanced-stage HCC 0.594418 small hepatocellular carcinoma 0.692383 HCC patients 0.615983	HCC worldwide 0.602122 single hepatocellular carcinoma 0.672174 Liver Italian Program 0.573612 early HCC 0.59445 entire liver 0.564284 Liver Diseases 0.560344 Gastroenterol Hepatol 0.566445 AASLD hepatocellular carcinoma 0.670773 untreated hepatocellular carcinoma 0.669362 study 0.562576 HCC detection 0.593776 liver function 0.561177 PUBMED Abstract 0.598546 early-stage HCC 0.580393 class A cirrhosis 0.563518 arterial blood 0.606167 liver transplant 0.559717 cirrhosis 0.620285 hepatitis b virus 0.59513 Abstract 0.629123 cirrhosis type B. 0.576124 Llovet JM 0.573361 cm hepatocellular carcinoma 0.677106 liver resection 0.566362	CLICK HERE
1731	National Cancer Institute	Html	en	Oral Contraceptives and Cancer Risk	A fact sheet about research on the association of oral contraceptive use (birth control pills) with risk of various cancers.	oral contraceptives 0.917263 hereditary ovarian cancer 0.383854 commonly prescribed type 0.33973 liver cancer risk 0.373941 estrogen-progestogen contraceptives 0.386723 benign liver tumors 0.371652 risk level 0.342841 increased risk 0.351993 time oral contraceptives 0.52153 ovarian cancer 0.597198 cervical cancers 0.357191 birth control pills 0.477503 cervical cancer 0.513015 female hormones 0.362642 hormonal factors 0.355222 widely used contraceptives 0.420798 slightly higher risk 0.352236 oral contraceptive formulations 0.41375 human papillomavirus 0.360793 endometrial cancer 0.391533 Cancer Epidemiology Biomarkers 0.379203 Cancer Clinical Study 0.356619 women 0.413442 study 0.369792 United States 0.339309	low progestin levels 0.339553 endometrial cancer risk 0.376136 oral contraceptive contains 0.427683 oral contraception 0.377158 breast cancers 0.339078 National Cancer Institute 0.35154 oral contraceptive. 0.39193 epithelial ovarian cancer 0.36885 female hormones estrogen 0.346135 ovarian cancer risk 0.5032 epidemiological studies 0.347746 cervical cancer risk 0.402371 higher risk 0.352753 hormonal contraceptives 0.40794 breast cancer risk 0.408785 protective effect increases 0.369195 Abstract 0.338219 breast cancer 0.500449 malignant liver tumors 0.371449 birth control pill 0.342382 cancer risk 0.531533 et al 0.421561 New England Journal 0.388183 cancer 0.613253	CLICK HERE
1846	National Cancer Institute	Html	es	Tratamiento del carcinoma de corteza suprarrenal (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de corteza suprarrenal.	Compton CC 0.317328 Hammer GD 0.357944 resection vs chemotherapy 0.309791 Sin embargo 0.386449 estadificación ensat 0.311064 largo plazo 0.314068 treatment utilization 0.307637 7th ed 0.317264 estadificación ajcc 0.311961 corteza suprarrenal benignos 0.333736 adrenal cortical carcinoma 0.326878 Instituto Nacional 0.323164 Radiat Oncol Biol 0.331552 Zaggia B 0.315343 Ardito A 0.314362 Terzolo M 0.35082 Basic Science 0.331876 Else T 0.335075 Clinical review 0.338841 corteza suprarrenal benignas 0.333037 ENSAT staging system 0.311888 Arch Surg 0.319608 Griffith K 0.315391 Feng M 0.318852 Fassnacht M 0.481992	Clin Endocrinol Metab 0.365561 estadio ii 0.316817 metástasis pulmonar 0.312599 Pfreundner L 0.316104 Angeli A 0.316386 Cancer Staging Manual 0.333671 adrenocortical carcinoma using 0.342814 National Cancer Institute 0.309404 PDQ Tratamiento 0.316742 New York 0.405075 Physician Data Query 0.30836 adrenocortical carcinoma 0.972403 Oncol Biol Phys 0.332857 Langenbecks Arch Surg 0.312314 Allolio B 0.353761 with adrenocortical carcinoma 0.336171 Byrd DR 0.316426 Union Internationale Contre 0.309764 American Joint Committee 0.309683 Sabolch A 0.315391 Ther Phys Biol 0.311534 Recurrent or metastatic 0.308748 Clinical Concepts 0.340059 AJCC Cancer Staging 0.33628	CLICK HERE
2010	National Cancer Institute	Html	es	Grados de comprobación científica de los estudios de investigación sobre detección y prevención del cáncer (PDQ®)–Versión para profesionales de salud	Información acerca de cómo evaluar la solidez de los datos probatorios obtenidos en los estudios de investigación sobre detección y prevención del cáncer.	Woolf SH 0.300601 Helfand M 0.300564 sección datos 0.302661 Current methods 0.300631 importancia clínica 0.300524 Consejo editorial usa 0.301821 datos probatorios indirectos 0.302664 Prev Med 0.300645 beneficios opción 0.300848 National Cancer Institute 0.300824 medida estudios 0.300552 Preventive Services Task 0.303591 Instituto Nacional 0.30261	Visuals Online 0.300487 intervenciones invasoras 0.300666 Harris RP 0.300578 Physician Data Query 0.300891 Services Task Force 0.303562 datos probatoriosUn estudio 0.301838 posibles beneficios 0.30077 datos probatorios 0.994126 acuerdo vs 0.301691 participantes vs 0.301672 US Preventive Services 0.301 perjuicios opción 0.301319 mejores estudios 0.300602	CLICK HERE
2956	National Cancer Institute	Html	en	Stress and Smoking	Many people smoke when they feel stressed. A major part of quitting smoking is finding ways to handle your stress. Get tips on ways you can reduce stress in your life.	mood 0.321745 yoga 0.311766 smokers 0.257588 effective—like 0.254092 body 0.252396 short walk 0.459288 lowers 0.345038 ways 0.478317 problem 0.256426 solution 0.253633 smoking 0.723433 things 0.251219 nicotine feel 0.464166 healthy ways 0.416006 oxygen 0.318701 quitting 0.25513	unpleasant feelings 0.498181 stress 0.995674 relaxation exercise 0.463458 cigarette 0.258889 emotions 0.253066 withdrawal 0.2602 Nicotine addiction 0.459283 brain 0.303202 people 0.263655 long-term stress reliever 0.883552 calms nerves 0.742794 cigarettes 0.42465 depression 0.30341 time 0.25441 better ways 0.410713 Cravings 0.267404	CLICK HERE
3413	National Cancer Institute	Html	en	Treatment Prevents Chemotherapy Side Effects for Children with Cancer	Adding aprepitant to the anti-nausea drug ondansetron, with or without dexamethasone, effectively prevents chemotherapy-induced nausea and vomiting in children.	Lancet Oncology 0.402095 approximately one-quarter 0.400434 Approximately half 0.380915 individual chemotherapy regimens 0.640029 pediatric oncologists 0.386544 primary endpoint 0.376989 accompanying editorial 0.359286 control group 0.648089 chemotherapy 0.797555 highly emetogenic chemotherapy 0.635176 pediatric patients 0.446593 pediatric dosing 0.38895 cancer therapy 0.375879 South Korea 0.360387 Final results 0.390611 poorer outcomes 0.360045 delayed phase 0.536277 well-designed anti-emetic study 0.496684 children 0.367409 pediatric anti-emetic regimens 0.524869 steroid dexamethasone 0.449436 retrospective reports 0.357625 Hyoung Jin Kang 0.507923 treatment-limiting complications 0.376302	moderate risk 0.374131 Richard Gralla 0.361364 vomiting 0.627585 anti-nausea drug 0.394817 clinical trial 0.39616 chemotherapy-induced nausea 0.735879 Fifty-one percent 0.401703 cancer patients 0.390213 trial results 0.359251 aprepitant group 0.947977 complete response 0.53189 study medications 0.371063 febrile neutropenia 0.569771 Seoul National University 0.506591 neurokinin-1 receptor antagonist 0.536858 serotonin receptor 0.391814 neutrophil count 0.368149 Pediatric Oncology Branch 0.516455 chemotherapy regimen patients 0.648708 antiemetic rescue medication—medication 0.520408 common adverse events 0.501689 Secondary endpoints 0.373589 Melinda Merchant 0.355445	CLICK HERE
15882	National Cancer Institute	Html	es	Cardo mariano (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.	Silybum marianum 0.735385 Agarwal R 0.945743 cell lines 0.375003 cell growth 0.494513 prostate carcinoma du145 0.373715 DNA synthesis 0.442196 carcinoma cell 0.46955 silybum marianum l 0.361146 Inhibitory effect 0.390679 Agarwal C 0.386743 receptor modulator activity 0.356592 Mol Carcinog 0.378538 Cancer Res 0.59348 carcinoma cell growth 0.407562 prostate carcinoma cells 0.4865 Singh RP 0.367955 flavonoid antioxidant 0.678831 active constituent 0.382485 Antiproliferative effect 0.363827 lipid peroxidation 0.585387 Biochem Pharmacol 0.461277 chemopreventive effects 0.369648 cardo lechero 0.365629 patients with 0.374862 cell growth inhibition 0.393232	Sonnenbichler J 0.428511 prostate carcinoma 0.590474 Campos R 0.414926 Pharmacol Res 0.429959 protective effects 0.379153 Biophys Res Commun 0.50103 prostate-specific antigen with 0.369145 carcinoma du145 cells 0.397873 Biochem Biophys Res 0.508991 Silymarin effects 0.38621 Biomed Res Int 0.385769 Clin Biol Res 0.375557 insulin-like growth factor-binding 0.358425 stimulatory effects 0.357205 Zhao J 0.53049 Guerra R 0.490633 with cell growth 0.41107 comparison with 0.378495 silibinin inhibits 0.378656 Planta Med 0.529049 protects against 0.371646 Mutat Res 0.369799 from silybum marianum 0.396284 Res Commun 0.505421	CLICK HERE
16049	National Cancer Institute	Html	en	Managing Costs and Medical Information	People with cancer may face major financial challenges and need help dealing with the high costs of care. Cancer treatment can be very expensive, even when you have insurance. Learn ways to manage medical information, paperwork, bills, and other records.	cancer treatment 0.452926 file folder 0.451204 emergency room 0.448618 medical bills 0.53618 state specific information 0.467913 insurance coverage 0.460494 health care team 0.51276 American Cancer Society 0.460319 payment options 0.46621 non-medical phone calls 0.432178 social worker 0.59281 clinical trials 0.467219 health care providers 0.479775 State Health Insurance 0.507522 cancer care 0.486022 research costs 0.450096 Track daily events 0.441284 Insurance Assistance Service 0.484543 health care costs 0.531061 patient care costs 0.553498 travel costs 0.463012 government health insurance 0.504906 treatment 0.485685 electronic medical record 0.447232 health care bills 0.536309	insurance company pay 0.509196 help finding referrals 0.489042 Cancer Information Service 0.588627 financial issues 0.432149 Health Insurance Assistance 0.617568 special email account 0.433974 sample chart 0.453844 discount drug programs 0.446076 separate folder 0.500544 extra costs 0.480459 bills 0.574419 hospital 0.455427 health care 0.679621 key medical information 0.460671 insurance company 0.914855 costs 0.714673 NCI Cancer Information 0.458766 important medical information 0.475214 human resources department 0.455264 medicine 0.454681 health care coverage 0.489272 insurance companies 0.472181 doctor 0.602384 mobile device 0.452113	CLICK HERE
16247	National Cancer Institute	Html	en	Examining the Effects of Presurgical Treatment for Prostate Cancer	In this study, men diagnosed with androgen-sensitive prostate cancer with intermediate- or high-risk features will be examined with mpMRI, undergo targeted biopsies, and be treated with neoadjuvant androgen deprivation therapy.	prostate tumors 0.614738 mpMRI scans 0.310993 new strategies 0.267582 potential tumor markers 0.311786 clinical trials 0.372782 targeted biopsy samples 0.322875 targeted lesions 0.294339 specific prostate lesions 0.476878 high-risk features 0.288054 newly diagnosed prostate 0.622232 metastatic prostate cancer 0.498919 prostate cancer cells 0.594259 surgically removed organs 0.312098 antiandrogen drug enzalutamide 0.322935 single imaging exam 0.312805 Dr. William Dahut 0.330786 systemic therapy 0.28819 neoadjuvant therapy 0.769289 aggressive prostate cancers 0.483417 protocol summary 0.275419 androgen-deprivation therapy 0.285401 NCI Center 0.275353 magnetic resonance imaging 0.315153 trial contact information 0.309223 United States 0.272406	intensive hormonal therapy 0.397524 high-risk prostate tumors 0.477739 prostatectomy specimens 0.282563 Treating Patients 0.272894 initial mpMRI scans 0.308885 high-risk prostate cancer 0.602491 radical prostatectomy 0.351855 NCI Clinical Trials 0.312784 common malignancy 0.274438 androgen-sensitive prostate cancer 0.480836 potential strategy 0.266185 Cancer Research 0.343151 anatomic imaging 0.268037 drug goserelin actetate 0.309432 targeted biopsies 0.292493 male sex hormones 0.320468 Goserelin Acetate 0.270879 high-risk disease 0.33068 prostate cancer 0.95691 neoadjuvant ADT 0.340784 aggressive disease 0.267926 prostate cancer recurrence 0.502931 specific lesions 0.287557 effective neoadjuvant therapy 0.348548	CLICK HERE
17173	National Cancer Institute	Html	es	Hongos medicinales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de los hongos medicinales como tratamiento para las personas con cáncer.	adjuvant immunochemotherapy with 0.310705 ganoderma lucidum 0.95261 Coriolus versicolor 0.338242 Ganoderma lucidum from 0.330019 triterpenoids from ganoderma 0.34341 from ganoderma spp 0.316446 extracted from ganoderma 0.316294 Se-enriched Ganoderma lucidum 0.325078 mushroom ganoderma lucidum 0.326878 cuáles pacientes 0.311657 adjuvant immunochemotherapy 0.310969 cells with immuno-stimulatory 0.308341 PSK may 0.326201 polysaccharides from ganoderma 0.316147 Ganoderma lucidum induces 0.347342 Oncol Rep 0.321721 Ganoderma lucidum polysaccharides 0.378912 Ganoderma lucidum mycelia 0.327066 pacientes supervivencia 0.312919 Ganoderma polysaccharides with 0.315786 patients with 0.347196 protein-bound polysaccharide psk 0.327993 lz-8 from ganoderma 0.316148 Ganoderma lucidum activities 0.328306 metabolites from ganoderma 0.315749	ganoderma lingzhi wu 0.315644 PSK quizás 0.327997 Ganoderma lucidum spores-induced 0.32738 from ganoderma lucidum 0.482816 oficiales ganoderma lucidum 0.327352 immunochemotherapy with psk 0.347115 PSK therapies 0.324706 isolated from ganoderma 0.330138 commercial ganoderma 0.31277 lucidum suppresses angiogenesis 0.315879 Ganoderma based 0.312698 ganoderma sinense zhao 0.315248 Mol Med 0.308288 gastric cancer 0.374999 extract from ganoderma 0.316948 immunochemotherapy with polysaccharide 0.311361 breast cancer 0.314008 Mushroom Science 0.307833 Ganoderma lingzhi from 0.316096 ganoderma lucidum triterpenoids 0.328168 PSK potencia 0.327619 Ganoderma lingzhi 0.323758 leukemia cells 0.314028 estudios cáncer 0.308153	CLICK HERE